Authors: MUHLSCHLEGAL F FONZI W HOYER L PAYNE T POULET FM CLEVENGER J LATGE JP CALERA J BEAUVAIS A PARIS S MONOD M STURTEVANT J GHANNOUM M NOZAWA Y CALDERONE R

Citation: F. Muhlschlegal et al., MOLECULAR MECHANISMS OF VIRULENCE IN FUNGUS-HOST INTERACTIONS FOR ASPERGILLUS-FUMIGATUS AND CANDIDA-ALBICANS, MEDICAL MYCOLOGY, 36, 1998, pp. 238-248

Authors: YOSHIDA Y KANG K LEIDICH S COOPER KD GHANNOUM M

Citation: Y. Yoshida et al., CANDIDA-ALBICANS INDUCES DIFFERENTIAL CYTOKINE PRODUCTION BY HUMAN BLOOD MONOCYTES, Journal of investigative dermatology, 110(4), 1998, pp. 667-667

Authors: BELANGER P NAST CC FRATTI R SANATI H GHANNOUM M

Citation: P. Belanger et al., VORICONAZOLE (UK-109,496) INHIBITS THE GROWTH AND ALTERS THE MORPHOLOGY OF FLUCONAZOLE-SUSCEPTIBLE AND FLUCONAZOLE-RESISTANT CANDIDA SPECIES, Antimicrobial agents and chemotherapy, 41(8), 1997, pp. 1840-1842

Authors: SANATI H BELANGER P FRATTI R GHANNOUM M

Citation: H. Sanati et al., A NEW TRIAZOLE, VORICONAZOLE (UK-109,496), BLOCKS STEROL BIOSYNTHESISIN CANDIDA-ALBICANS AND CANDIDA-KRUSEI, Antimicrobial agents and chemotherapy, 41(11), 1997, pp. 2492-2496

Authors: SANATI H MESSER SA PFALLER M WITT M LARSEN R ESPINELINGROFF A GHANNOUM M

Citation: H. Sanati et al., MULTICENTER EVALUATION OF BROTH MICRODILUTION METHOD FOR SUSCEPTIBILITY TESTING OF CRYPTOCOCCUS-NEOFORMANS AGAINST FLUCONAZOLE, Journal of clinical microbiology, 34(5), 1996, pp. 1280-1282

Authors: CURRIE BP GHANNOUM M BESSEN L CASADEVALL A

Citation: Bp. Currie et al., DECREASED FLUCONAZOLE SUSCEPTIBILITY OF A RELAPSE CRYPTOCOCCUS-NEOFORMANS ISOLATE AFTER FLUCONAZOLE TREATMENT, Infectious diseases in clinical practice, 4(4), 1995, pp. 318-319